A rumor regarding Qiagen was highlighted in Ben Harrington’s M&A-focused Betaville blog, contacts tell The Fly.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on QGEN:
- QIAGEN N.V. to release results for Q4 2023 and hold webcast
- Qiagen receives FDA clearance for NeuMoDx CT/NG Assay 2.0
- QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems
- Qiagen announces plans to return approximately $300M to shareholders
- QIAGEN announces plans to return approximately $300 million to shareholders